Corrigendum to “Development of a stable inhalable dry powder formulation with osteoglycin fragment for alveolar epithelial repair” [Int. J. Pharm. 682 (2025) 125913]

IF 5.2 2区医学 Q1 PHARMACOLOGY & PHARMACY

International Journal of Pharmaceutics Pub Date : 2025-07-18 DOI:10.1016/j.ijpharm.2025.125968

Luke van der Koog , Evalyne M Jansen , Robin A.B. Elferink , Sophie I.T. Bos , Anika Nagelkerke , Reinoud Gosens , Henderik W. Frijlink , Wouter L.J. Hinrichs

引用次数: 0

查看原文本刊更多论文

“用于肺泡上皮修复的稳定可吸入干粉制剂与骨苷片段的开发”的勘误表[Int.]中华医学杂志。682 (2025)125913 [j]

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

International Journal of Pharmaceutics 医学-药学

CiteScore

10.70

自引率

8.60%

发文量

951

审稿时长

72 days

期刊介绍： The International Journal of Pharmaceutics is the third most cited journal in the "Pharmacy & Pharmacology" category out of 366 journals, being the true home for pharmaceutical scientists concerned with the physical, chemical and biological properties of devices and delivery systems for drugs, vaccines and biologicals, including their design, manufacture and evaluation. This includes evaluation of the properties of drugs, excipients such as surfactants and polymers and novel materials. The journal has special sections on pharmaceutical nanotechnology and personalized medicines, and publishes research papers, reviews, commentaries and letters to the editor as well as special issues.